Doxorubicin-loaded human serum albumin nanoparticles overcome transporter-mediated drug resistance in drug-adapted cancer cells
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: Beilstein journal of nanotechnology, 10.2019, S. 1707-1715
- Ereignis
-
Veröffentlichung
- (wo)
-
Frankfurt am Main
- (wer)
-
Universitätsbibliothek Johann Christian Senckenberg
- (wann)
-
2019
- Urheber
-
Onafuye, Hannah
Pieper, Sebastian
Mulac, Dennis
Cinatl, Jindrich
Wass, Mark N.
Langer, Klaus
Michaelis, Martin
- DOI
-
10.3762/bjnano.10.166
- URN
-
urn:nbn:de:hebis:30:3-733486
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:47 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Onafuye, Hannah
- Pieper, Sebastian
- Mulac, Dennis
- Cinatl, Jindrich
- Wass, Mark N.
- Langer, Klaus
- Michaelis, Martin
- Universitätsbibliothek Johann Christian Senckenberg
Entstanden
- 2019
Ähnliche Objekte (12)
Drug repurposing: omeprazole increases the efficacy of acyclovir against herpes simplex virus type 1 and 2
Multifaceted roles of SAMHD1 in cancer
Multifaceted roles of SAMHD1 in cancer
Doxorubicin-loaded human serum albumin nanoparticles overcome transporter-mediated drug resistance
Reduced interferon antagonism but similar drug sensitivity in Omicron variant compared to Delta variant SARS-CoV-2 isolates
SARS-CoV-2 Omicron variant virus isolates are highly sensitive to interferon treatment
Impact of the COVID-19 pandemic on the circulation of other pathogens in England
SARS-CoV-2 Omicron variant virus isolates are highly sensitive to interferon treatment
COVID-19-related coagulopathy - is transferrin a missing link?
Synergism of interferon-beta with antiviral drugs against SARS-CoV-2 variants
The story of human cytomegalovirus and cancer: increasing evidence and open questions
Effects of flavonoid-induced oxidative stress on anti-H5N1 influenza A virus activity exerted by baicalein and biochanin A
Drug repurposing: omeprazole increases the efficacy of acyclovir against herpes simplex virus type 1 and 2
Multifaceted roles of SAMHD1 in cancer
Multifaceted roles of SAMHD1 in cancer
Doxorubicin-loaded human serum albumin nanoparticles overcome transporter-mediated drug resistance
Reduced interferon antagonism but similar drug sensitivity in Omicron variant compared to Delta variant SARS-CoV-2 isolates
SARS-CoV-2 Omicron variant virus isolates are highly sensitive to interferon treatment
Impact of the COVID-19 pandemic on the circulation of other pathogens in England
SARS-CoV-2 Omicron variant virus isolates are highly sensitive to interferon treatment
COVID-19-related coagulopathy - is transferrin a missing link?
Synergism of interferon-beta with antiviral drugs against SARS-CoV-2 variants
The story of human cytomegalovirus and cancer: increasing evidence and open questions
Effects of flavonoid-induced oxidative stress on anti-H5N1 influenza A virus activity exerted by baicalein and biochanin A
Drug repurposing: omeprazole increases the efficacy of acyclovir against herpes simplex virus type 1 and 2
Multifaceted roles of SAMHD1 in cancer
Multifaceted roles of SAMHD1 in cancer
Doxorubicin-loaded human serum albumin nanoparticles overcome transporter-mediated drug resistance
Reduced interferon antagonism but similar drug sensitivity in Omicron variant compared to Delta variant SARS-CoV-2 isolates
SARS-CoV-2 Omicron variant virus isolates are highly sensitive to interferon treatment
Impact of the COVID-19 pandemic on the circulation of other pathogens in England
SARS-CoV-2 Omicron variant virus isolates are highly sensitive to interferon treatment
COVID-19-related coagulopathy - is transferrin a missing link?
Synergism of interferon-beta with antiviral drugs against SARS-CoV-2 variants
The story of human cytomegalovirus and cancer: increasing evidence and open questions